SS
VBIV

Steve Schonfeld’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History

Steve Schonfeld’s Portfolio VBIV Stock Details VBIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-2,367
Closed -$166K – 3000
2021
Q4 		$166K Sell
2,367
-850
-26% -$71.6K ﹤0.01% 1787
2021
Q3 		$300K Buy
3,217
+338
+12% +$32.1K ﹤0.01% 1530
2021
Q2 		$290K Buy
+2,879
New +$281K ﹤0.01% 1501

Other funds holding VBIV

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
GAI
General American Investors New York $1.69B AUM 40.94% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Rafferty Asset Management
Rafferty Asset Management New York $43.9B AUM 121.74% 1-Year Est. Return

Steve Schonfeld's VBIV Position: Q1 2022 in Review

Steve Schonfeld sold out of VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) in Q1 2022, closing a stake of 2,367 shares — an estimated $166K sold.

Steve Schonfeld first reported a position in VBIV in Q2 2021 and held it in 3 quarters. The position peaked at $300K in Q3 2021. 131 funds tracked by Wall St. Rank hold VBIV as of Q1 2022.

  • Steve Schonfeld reported no remaining VBI Vaccines, Inc. New Common Stock (Canada) position as of Q1 2022 after selling out during the quarter.
  • Steve Schonfeld sold 2,367 VBI Vaccines, Inc. New Common Stock (Canada) shares in Q1 2022, an estimated $166K.
  • Steve Schonfeld first reported a position in VBI Vaccines, Inc. New Common Stock (Canada) in Q2 2021 and held it in 3 quarters.
  • Steve Schonfeld's VBI Vaccines, Inc. New Common Stock (Canada) position peaked at $300K in Q3 2021.
  • 131 funds tracked by Wall St. Rank held VBI Vaccines, Inc. New Common Stock (Canada) as of Q1 2022.

Based on Schonfeld Strategic Advisors's 13F filing for Q1 2022, filed 16 May 2022.